Amisulpride and Movement - uncontrolled or slow - a phase IV clinical study of FDA data
Summary:
Movement - uncontrolled or slow is reported as a side effect among people who take Amisulpride (amisulpride), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Olanzapine, and have Schizophrenia.
The phase IV clinical study analyzes which people have Movement - uncontrolled or slow when taking Amisulpride. It is created by eHealthMe based on reports of 6,364 people who have side effects when taking Amisulpride from the FDA, and is updated regularly.
What is Amisulpride?
Amisulpride has active ingredients of amisulpride. eHealthMe is studying from 6,389 Amisulpride users. Check the latest studies of Amisulpride.
What is Movement - uncontrolled or slow?
Movement - uncontrolled or slow is found to be associated with 797 drugs and 1,856 conditions by eHealthMe. Check the latest studies of Movement - uncontrolled or slow.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
6,364 people reported to have side effects when taking Amisulpride.
Among them, 136 people (2.14%) have Movement - uncontrolled or slow.

Among these 136 people:
How long have people been on Amisulpride when they have Movement - uncontrolled or slow? *
What is the gender of people who have Movement - uncontrolled or slow when taking Amisulpride? *
What is the age of people who have Movement - uncontrolled or slow when taking Amisulpride? *
What are other drugs people take besides Amisulpride? *
What are other side effects people have besides Movement - uncontrolled or slow? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Amisulpride and have Movement - uncontrolled or slow?
- Check whether Movement - uncontrolled or slow is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Amisulpride:
- Amisulpride (6,389 reports)
Movement - uncontrolled or slow treatments and more:
- Movement - uncontrolled or slow (26,876 reports)
How severe was Movement - uncontrolled or slow and when was it recovered:
Expand to all the drugs that have ingredients of amisulpride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Amisulpride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Movement - uncontrolled or slow:
- Movement - uncontrolled or slow (797 drugs)
Browse all the conditions that are associated with Movement - uncontrolled or slow:
- Movement - uncontrolled or slow (1,856 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on amisulpride (the active ingredients of Amisulpride) and Amisulpride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Atovaquone cause Alanine Aminotransferase Increased? - 7 seconds ago
- Ambien and Hydramine drug interactions for women aged 30-39 - 14 seconds ago
- Methylprednisolone and Skelaxin drug interactions for women aged 50-59 - 55 seconds ago
- Ms Contin and Fish Oil drug interactions for women aged 50-59 - a minute ago
- Jardiance and Hypertension Aggravated for Men aged 60+ - a minute ago
- Lansoprazole and Lymphadenopathy for Women aged 20-29 - a minute ago
- Lansoprazole and Lymph Follicular Hypertrophy for Women aged 20-29 - a minute ago
- Livalo and Plavix drug interactions for men aged 60+ - a minute ago
- Dizziness in Vitamin E, how severe and when it was recovered? - a minute ago
- Could Allegra cause Cd4 Lymphocytes Decreased? - a minute ago